Sonire Therapeutics

Tokyo, Japan · Founded 2020 · Privately Held (backing)

Developer of high-intensity focused ultrasound therapy systems designed to revolutionize medical therapy for the treatment of cancer patients. Sonire Therapeutics is based in Tokyo, Japan and was founded in 2020. Its last reported valuation was $31.7 million in Nov 2022. It has raised $39.9 million across 1 recorded round; the latest was a $13.5 million early-stage round in Mar 2026.

Last reported valuation
$31.7M
Oct 2026
Priced at
—
Total raised
$39.9M
Last round
Early Stage VC
Mar 2026

Who backs Sonire Therapeutics?

27 investors
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Sonire Therapeutics investors

27 investors are on record for Sonire Therapeutics, including MedTech Innovator, Mitsubishi UFJ Capital, SBI Investment and J-Startup. The early-stage round in Mar 2026 drew 1 investor.

Free account
More of Sonire Therapeutics with a free account
  • ·The complete investor list: 27 names
  • ·Watch Sonire Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 27 firms already write checks for companies like Sonire Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View